REGENEREX PHARMA, INC. Depreciation and Amortization
REGENEREX PHARMA, INC. reported Depreciation and Amortization of $3.58 thousand for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-31
- REGENEREX PHARMA, INC. depreciation, depletion and amortization for the quarter ending 2019-12-31 was $1.34K, a 0.07% decline year-over-year.
- REGENEREX PHARMA, INC. depreciation, depletion and amortization for the quarter ending 2018-12-31 was $1.34K.
- REGENEREX PHARMA, INC. depreciation, depletion and amortization for fiscal 2025 was $3.05K.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.58K 10-KT · filed 2026-08-31 | |||
| 2025-03-31 | $3.05K 10-KT · filed 2026-08-31 | |||
| 2019-12-31 | $1.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $4.02K 10-Q · filed 2020-02-10 | ||
| 2019-09-30 | $2.67K 10-Q · filed 2019-10-30 | |||
| 2018-12-31 | $1.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $4.02K 10-Q · filed 2020-02-10 | ||
| 2018-09-30 | $2.67K 10-Q · filed 2019-10-30 | |||
| 2017-12-31 | $1.34K 10-Q · filed 2019-02-04 |